Loyens & Loeff: Solvias on the acquisition of Cergentis

Solvias, an independent pharmaceutical testing and manufacturing company, has acquired Netherlands-based Cergentis to bolster its biologics and cell & gene therapy testing capabilities.

Cergentis marks Solvias’ second acquisition since partnering with health care investors Water Street Healthcare Partners and JLL Partners in 2020. The Switzerland based company has recruited industry leaders to join its board and commenced a program to significantly upgrade and expand its information technology platform and infrastructure to support its plans for global expansion.

With global sales of cell & gene therapies projected to accelerate at a 63% compound annual growth rate, more researchers require sophisticated solutions to validate the safety & efficacy of these advanced new therapies. Cergentis enables Solvias to provide customers with proprietary technology and knowledge steeped in fast-evolving genomic techniques that support effective decision-making and R&D program design.

Loyens & Loeff Switzerland was involved on the deal.

Loyens & Loeff: Solvias on the acquisition of Cergentis



Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram